Excision Repair Cross-complementation Group 1 is a Prognostic Biomarker in Patients with Colorectal Cancer Receiving Chemotherapy

BACKGROUND: Conflicting results about the association between expression level of excision repair cross-complementation group 1 (ERCC1) and clinical outcome in patients with colorectal cancer (CRC) receiving chemotherapy have been reported. Thus, we searched the available articles and performed the...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Chin Med J (Engl)
Главные авторы: Li, Mu-Xing, Bi, Xin-Yu, Zhao, Hong, Huang, Zhen, Han, Yue, Zhao, Dong-Bin, Zhao, Jian-Jun, Cai, Jian-Qiang
Формат: Artigo
Язык:Inglês
Опубликовано: Medknow Publications & Media Pvt Ltd 2016
Предметы:
Meta Analysis
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4804441/
https://ncbi.nlm.nih.gov/pubmed/26904994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0366-6999.176993
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы